9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9219B |
Orphenadrine Screen, Blood |
9237U |
Phenylpropanolamine Screen, Urine |
9248B |
Pseudoephedrine Screen, Blood |
9248SP |
Pseudoephedrine Screen, Serum/Plasma |
9248U |
Pseudoephedrine Screen, Urine |
9293B |
Methylenedioxymethamphetamine and Metabolite Screen, Blood |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |